Allianz Asset Management
MIRM icon

Allianz Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Allianz Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$773K Sell
6,600
-24,655
-79% -$2.48M ﹤0.01% 1935
2026
Q1 		$2.89M Buy
31,255
+3,811
+14% +$359K ﹤0.01% 1413
2025
Q4 		$2.17M Buy
27,444
+24,644
+880% +$1.77M ﹤0.01% 1514
2025
Q3 		$205K Buy
+2,800
New +$178K ﹤0.01% 1952
2025
Q2 		– Sell
-6,500
Closed -$293K – 2187
2025
Q1 		$293K Buy
6,500
+700
+12% +$33K ﹤0.01% 2048
2024
Q4 		$240K Buy
+5,800
New +$242K ﹤0.01% 2066

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allianz Asset Management's MIRM Position: Q2 2026 in Review

Allianz Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 79% in Q2 2026, selling an estimated $2.48M and leaving 6,600 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

Allianz Asset Management first reported a position in MIRM in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.89M in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Allianz Asset Management held 6,600 shares of Mirum Pharmaceuticals worth $773K as of Q2 2026.
  • Allianz Asset Management sold 24,655 Mirum Pharmaceuticals shares in Q2 2026, an estimated $2.48M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1935 holding.
  • Allianz Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Allianz Asset Management's Mirum Pharmaceuticals position peaked at $2.89M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.